pemafibrate
Kowa Pharmaceuticals
[]
 &gt;effects of pemafibrate (...) were 26.2% for triglycerides, 25.8% for very-low-density lipoprotein (vldl) cholesterol, 25.6% for remnant cholesterol (...) and 4.8% for apolipoprotein b sounds like it reduced the amount of tg in the particles, but not the particle number.
A monster from the what-is-true dimension.

N&R: ????????

L: ??????????????????????????